Literature DB >> 25972149

Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?

Yuhua Xue1, George Michalopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25972149     DOI： 10.1007/s10620-015-3687-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.

Authors:  D Sánchez-Muñoz; V M Castellano-Megías; M Romero-Gómez
Journal:  Dig Liver Dis       Date:  2007-01-30       Impact factor: 4.088

2.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury.

Authors:  George K Michalopoulos; Lindsay Barua; William C Bowen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

3.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

Review 4.  Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities.

Authors:  V J Desmet
Journal:  Mayo Clin Proc       Date:  1998-01       Impact factor: 7.616

5.  Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin.

Authors:  Hermelijn H Smits; Anneke Engering; Desiree van der Kleij; Esther C de Jong; Kim Schipper; Toni M M van Capel; Bas A J Zaat; Maria Yazdanbakhsh; Eddy A Wierenga; Yvette van Kooyk; Martien L Kapsenberg
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

6.  Depletion of Foxp3+ Regulatory T Cells Promotes Profibrogenic Milieu of Cholestasis-Induced Liver Injury.

Authors:  Yoon Seok Roh; Surim Park; Chae Woong Lim; Bumseok Kim
Journal:  Dig Dis Sci       Date:  2014-11-22       Impact factor: 3.199

Review 7.  A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage.

Authors:  Lawrence Steinman
Journal:  Nat Med       Date:  2007-02       Impact factor: 53.440

Review 8.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

9.  Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

Authors:  Ruth Y Lan; Chunmei Cheng; Zhe-Xiong Lian; Koichi Tsuneyama; Guo-Xiang Yang; Yuki Moritoki; Ya-Hui Chuang; Takafumi Nakamura; Shigeru Saito; Shinji Shimoda; Atsushi Tanaka; Christopher L Bowlus; Yasuo Takano; Aftab A Ansari; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

Review 10.  The role of stem cells in liver repair and fibrosis.

Authors:  Linda E Greenbaum; Rebecca G Wells
Journal:  Int J Biochem Cell Biol       Date:  2009-11-13       Impact factor: 5.085
  10 in total
  2 in total

1.  Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.

Authors:  Simon D Lytton; Marcin Osiecki; Bożena Cukrowska; Aldona Wierzbicka; Maria Goliszek; Piotr Socha; Wojciech Janczyk; Dilek Dayanakli; Dieter Abendroth; Sabine Kramp; Kai Fechner; Thomas Scheper; Michael Mahler; Chelsea Bentow; Dimietrios Bogdanos; Dietmar Fuchs; Marek Woynarowski
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 2.  Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.

Authors:  Chong-Yang Zhang; Wei-Gang Yuan; Pei He; Jia-Hui Lei; Chun-Xu Wang
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.